MyAverix Finance
KQ · Healthcare
Aimed Bio (0009K0)
Biotechnology
Aimed Bio (0009K0) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $2.16T, P/E ratio is 25.00, net margin is 10.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0009K0
Aimed Bio (0009K0) — FAQ
What is Aimed Bio's market cap?
Aimed Bio (0009K0) has a reported market cap of $2.16T (data as of 2026-05-22).
What is 0009K0's P/E ratio?
The price-to-earnings (P/E) ratio for Aimed Bio (0009K0) is 25.00 (data as of 2026-05-22).
Does Aimed Bio pay a dividend?
Dividend yield is not available in the current snapshot for Aimed Bio (0009K0). Check the MyAverix Finance app for the latest dividend data.
What sector is Aimed Bio in?
Aimed Bio (0009K0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 0009K0 listed on?
0009K0 is listed on KQ.
What is Aimed Bio's net margin?
Aimed Bio (0009K0) reports a net margin of 10.6% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.